I am a
Paschim Vihar, New Delhi care@kpcirc.org

For employers & institutions

Cancer arrives at work before it arrives at a hospital.

Someone takes leave they cannot explain. Then months of disorganised absence while a family tries to coordinate care nobody is coordinating. Cover changes both halves.

₹600–1,500
Per employee, per year, banded by headcount and scope
Aggregate
Reporting only, no individual clinical data ever reaches you
Same day
Navigator engaged from the point of diagnosis
A community screening camp with a recording sheet in use

A camp with a denominator. How many screened, how many positive, and, the number almost nobody measures, how many actually reached a diagnosis.

What the contract buys

Four things, none of them a benefit brochure

01 · Before anything happens

Risk assessment & on-site screening

  • Cancer risk assessment available to every employee, at no charge to them
  • On-site camps designed for your workforce's actual exposure profile, tobacco and areca nut in a manufacturing plant is a different programme from a desk-based office
  • Oral, breast and cervical screening as the default trio, because that is where India's burden and detectability overlap
  • Tobacco and areca-nut cessation, run as a programme rather than a poster
02 · The moment something is found

Second opinion & navigator

  • A written second-opinion entitlement for any employee or dependant diagnosed, theirs to use anywhere, including against a plan we did not write
  • A named OnKommon Navigator engaged from diagnosis, coordinating appointments, records, tests and recall
  • The cost desk: total course costing, clinically equivalent cheaper medicines, and the government schemes they are entitled to
03 · Getting back

Return-to-work

  • Functional and fatigue assessment before a return date is agreed
  • A phased-return plan your HR team can actually implement
  • The documentation an Indian employer needs, written to be usable rather than defensive
  • Ongoing rehabilitation through our own physiotherapy service
04 · What you see

Quarterly utilisation report

  • How many employees used the assessment, the camps, the opinion entitlement
  • Camp yield: screened, positive, and, the number that matters, reached a diagnosis
  • Aggregate exposure and risk profile of the workforce, to shape next year's programme
  • Aggregate and anonymised. Always.

The line we do not cross

The employee is our patient, not yours

This is the clause that makes an employer programme usable. Without it, employees do not participate, and a screening programme nobody trusts is worse than none, because it produces a false sense that the risk has been managed.

You never receive

A diagnosis. A screening result. An attendance record at any clinic. A name attached to any finding. A list of who used the service.

You receive

Aggregate, anonymised utilisation and yield. And, where a fitness determination is separately contracted, only the determination, never the clinical detail behind it.

How a case moves

Employee uses the assessmentFree to them, no approval from you, no record to you
Something is foundSame-day handover to a named navigator
Second opinion entitlement engagedWritten, independent, usable anywhere
Treatment, coordinatedWherever it happens. Their oncologist keeps the case.
Return-to-work planDocumentation to HR; clinical detail stays with the employee
You see the quarterly reportAggregate numbers, never a person

Pricing

Per employee, per year

Banded by headcount and by which of the four components you take. Annual contract, invoiced to the organisation.

Scroll the table sideways →
BandPer employee / yearIncludes
Assess₹600Risk assessment for every employee, one on-site camp a year, cessation programme, quarterly report.
Assess + Opinion₹1,000The above, plus a written second-opinion entitlement for any employee or dependant diagnosed.
Full cover₹1,500The above, plus navigator engagement from diagnosis, the cost desk, and return-to-work assessment.

Screening investigations performed at a camp are billed at partner diagnostic rates, quoted per programme before it runs, they are not inside the per-employee fee. Molecular testing, imaging, treatment and procedures are billed to the patient or their insurer by whoever provides them. This is a service contract, not an insurance product: it does not reimburse treatment cost.

Detection is the whole argument. India's highest-burden cancers are among its most detectable, and a workforce is a defined population you can actually reach.

Why an employer, specifically

You have something a health system does not

A defined population, a way to reach every one of them, and a reason they will turn up. Public screening programmes spend most of their effort on those two problems.

We make no claim about outcomes or cost savings, and we will not present one. The quarterly report tells you what actually happened, how many were screened, how many findings, and how many reached a diagnosis. Judge it on that.

Start with one camp

Run a single on-site screening camp before committing to an annual contract. You will see the yield, your people will see what it is like, and we will both find out whether this is worth doing at your scale.

Take this away

Return to Work Guide

return-to-work.pdf · 6–8 pp · free, no login and no email capture

Download the PDF All 24 guides